Sign up to see all 5.
None.
No insider has filed a notice of proposed sale (Form 144) for Parabilis Medicines Inc in the last 12 months.
There are not yet two fiscal years of reported share counts for Parabilis Medicines Inc.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
RC
Ra Capital Management, L.P.
13D · 23.8%
|
28.9M | 100.09% | NEW | Q2 '26 | 6.9% | |
|
Shares held by quarter
Peak holding28.9M (Q2'26)
Change over 8 quarters+28.9M
Share of the company100.090%
Disclosed stake13D · 23.8%
|
||||||
|
F
FMR LLC
|
10.3M | 35.60% | NEW | Q2 '26 | 0.0% | |
|
Shares held by quarter
Peak holding10.3M (Q2'26)
Change over 8 quarters+10.3M
Share of the company35.600%
|
||||||
23 more super investors behind a free account
See every manager holding Parabilis Medicines Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$30.7M | 1.1M | 3.88% | 0.00% | June 30, 2026 |
|
VS
Vanguard Index Funds
|
$22.1M | 807.8K | 2.79% | 0.01% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Parabilis Medicines Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
PK
Peter Kolchinsky
5%+ holder
13D · 23.8%
|
28.9M | 100.09% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
RS
Rajeev Shah
5%+ holder
13D · 23.8%
|
28.9M | 100.09% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
4 more holders behind a free account
See every insider and 5%+ holder of Parabilis Medicines Inc.
Sign up freeLoading...